| [1] |
Mellas S, Bouchikhi AA, Tazi MF,et al. Primary pleomorphic undifferentiated sarcoma-a rare renal localization: a case report[J]. Case Rep Urol, 2012，2012: 862493.
|
| [2] |
Hwang SS, Park SY, Park YH. The CT and F-FDG PET/CT appearance of primary renal malignant fibrous histiocytoma[J]. J Med Imaging Radiat Oncol, 2010, 54(4):365-367
|
| [3] |
O'Brien JE, Stout AP. Malignant fibrous xanthomas[J]. Cancer, 1964, 17(4): 1445-1455.
|
| [4] |
Strauchen JA, Bona D. A Malignant fibrous histiocytoma. Expression of monocyte/macrophage differentiation antigens detected with monoclonal antibodies[J]. Am J Pathol, 1986, 124(2): 303-309.
|
| [5] |
Schneider JA, König H, Hertel E. Malignant fibrous histiocytoma of the renal capsule[J]. Br J Urol, 1992, 69(4): 435-436.
|
| [6] |
Kim SJ, Ahn BC, Kim SR, et al. Primary malignant fibrous histiocytoma of the kidney[J]. Yonsei Med J, 2002, 43(3): 399-402.
|
| [7] |
Muretto P, Lemma E, Grianti C, et al. Inflammatory malignant fibrous histiocytoma of the kidney: An immunohistochemical and ultrastructural study[J]. Tumori, 1985, 71(2): 147-153.
|
| [8] |
Çilesiz NC, Erdoğan N, Özkan A, et al. Pleomorphic undifferentiated sarcoma: A case of a giant renal mass[J]. Urol Case Rep, 2018, 17: 44-47.
|
| [9] |
Ptochos A, Karydas G, Iosifidis N, et al. Primary malignant fibrous histiocytoma[J]. Urol Int, 1999, 63(4): 261-264.
|
| [10] |
Zhu Y, Hao D, Tang X, et al. Undifferentiated high-grade pleomorphic sarcoma of ethmoid sinus: a case report and literature review[J]. Braz J Otorhinolar, 2018, 84(3): 389-392.
|
| [11] |
江文辉, 温江妹, 许春伟, 等. 未分化多形性肉瘤的临床病理分析[J]. 临床与病理杂志, 2020, 40(4): 837-842.
|
| [12] |
Göğüş Ç, Gökce Mİ, Süer E, et al. Primary malignant fibrous histiocytoma of the kidney: report of a case and literature review[J]. Turk J Urol, 2013, 39(3): 194-197.
|
| [13] |
王水, 赵惠芳. 肾脏原发性未分化多形性肉瘤MSCT诊断及病理对照研究[J]. 现代肿瘤医学, 2017, 25(19): 3104-3107.
|
| [14] |
Abbert H, Wagner R, Becht E. Malignant fibrous histocytoma of renal capsule[J]. J Cancer Res Clin Oncol, 1981, 100(3): 285-293.
|
| [15] |
Gil-Julio H, Vazquez-Alonso F, Puche-Sanz I, et al. Conservative treatment of malignant fibrous histiocytoma of the kidney: a case report[J]. Curr Urol, 2012, 6(1): 46-49.
|
| [16] |
Singh SK, Mandal AK, Agarwal MM, et al. Primary renal inflammatory malignant fibrous histiocytoma: a diagnostic challenge[J]. Int J Urol. 2006, 13(7): 1000-1002
|
| [17] |
Froehner M, Manseck A, Haase M, et al. Locally recurrent malignant fibrous histiocytoma: a rare and aggressive genitourinary malignancy[J]. Urol Int, 1999, 62(3): 164-170.
|
| [18] |
Sugihara T, Fujimura T, Kume H, Homma Y. Successful treatment of metastatic malignant fibrous histiocytoma of the kidney[J]. Urol Int, 2010, 85(1): 118-120.
|
| [19] |
Tarjan M, Cserni G, Szabo Z，et al. Malignant fibrous histiocytoma of the kidney[J]. Scand J Urol Nephrol, 2001, 35(6):518-520.
|
| [20] |
Clinton S, Steyn J. Renal Malignant Fibrous Histiocytoma[J]. Br J Urol, 1990, 65(1): 109-111
|
| [21] |
Cormio L, Sanguedolce F, Massenio P, et al. Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney[J]. The Open Urol & J Nep, 2014, 7(1):1-3
|
| [22] |
Singh SK, Mandal AK, Agarwal MM, et al. Primary renal inflammatory malignant fibrous histiocytoma: A diagnostic challenge[J]. Int J Urol, 2006, 13(7): 1000-1002
|
| [23] |
Chen Y, Rao D, Zhu H, et al. Primary malignant fibrous histiocytoma of the renal pelvis: a 78-month follow-up case report[J]. Onco Targets and therapy, 2013, 7: 1-3
|
| [24] |
Antman K, Crowley J, Balcerzak SP, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas[J]. J Clin Oncol, 1993, 11(7): 1276-1285
|
| [25] |
Sugihara T, Fujimura T, Kume H, et al. Successful treatment of metastatic malignant fibrous histiocytoma of the kidney[J]. Urol Int, 2010, 85(1): 118-120
|
| [26] |
Hsiao PJ, Chen GH, Chang YH, et al. An unresectable retroperitoneal malignant fibrous histiocytoma: A case report[J]. Oncol Lett, 2016, 11(4): 2403-2407
|
| [27] |
ChI Y, Sun Y, Cai J, et al. Phase Ⅱ study of anlotinib for treatment of advanced soft tissues sarcomas[J]. J Clin Oncol,2016, 34(15): 11005.
|
| [28] |
罗春莉, 李志平. 软组织肉瘤的分子靶向治疗研究进展[J]. 中国癌症杂志, 2019, 29(10): 824-831.
|
| [29] |
Que Y, Zhang XL, Liu ZX, et al. Frequentamplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1blockade combination in soft tissue sarcoma[J]. J Immunother Cancer, 2021; 9(2): e001696.
|